{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:21:32Z","timestamp":1767853292805,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ministry of Health and Welfare, Executive Yuen, Taiwan","award":["MOHW-10646"],"award-info":[{"award-number":["MOHW-10646"]}]},{"name":"Ministry of Health and Welfare, Executive Yuen, Taiwan","award":["MOHW-10243"],"award-info":[{"award-number":["MOHW-10243"]}]},{"name":"Ministry of Health and Welfare, Executive Yuen, Taiwan","award":["MOHW-10740"],"award-info":[{"award-number":["MOHW-10740"]}]},{"name":"Ministry of Health and Welfare, Executive Yuen, Taiwan","award":["MOHW-10444"],"award-info":[{"award-number":["MOHW-10444"]}]},{"name":"Ministry of Health and Welfare, Executive Yuen, Taiwan","award":["MOHW-10445"],"award-info":[{"award-number":["MOHW-10445"]}]},{"name":"Ministry of Science and Technology, Executive Yuen, Taiwan","award":["MOST 106-2627-M-006-015"],"award-info":[{"award-number":["MOST 106-2627-M-006-015"]}]},{"name":"Ministry of Science and Technology, Executive Yuen, Taiwan","award":["MOST 107-2627-M-006-007"],"award-info":[{"award-number":["MOST 107-2627-M-006-007"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.drugalcdep.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T19:13:50Z","timestamp":1561058030000},"page":"197-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0551-1999","authenticated-orcid":false,"given":"Kun-Chia","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Ying","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hsueh","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Shiang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ni","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo-Yen","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/SAR.S14871","article-title":"Drug use trajectory patterns among older drug users","volume":"2","author":"Boeri","year":"2011","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.bp.112.111583","article-title":"Cost-effectiveness of injectable opioid treatment v. Oral methadone for chronic heroin addiction","volume":"203","author":"Byford","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2015.05.033","article-title":"Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan","volume":"153","author":"Chang","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2016.12.003","article-title":"Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan","volume":"43","author":"Chang","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0929-6646(08)60078-9","article-title":"Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population","volume":"106","author":"Chang","year":"2007","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0030","doi-asserted-by":"crossref","first-page":"30266","DOI":"10.1038\/srep30266","article-title":"Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addbeh.2017.03.028","article-title":"Opioid users with comorbid hepatitis C spent more time in agonist therapy: a 6-year observational study in Taiwan","volume":"72","author":"Chen","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/15504263.2017.1363449","article-title":"Psychological distress is correlated with erectile dysfunction among patients receiving methadone maintenance in Taiwan","volume":"13","author":"Cheng","year":"2017","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0045","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0050","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.330.7503.1297","article-title":"Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials","volume":"330","author":"Dijkgraaf","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcl141","article-title":"Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy","volume":"100","author":"Fang","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/MLR.0b013e31814848f1","article-title":"US norms for six generic health-related quality-of-life indexes from the National Health Measurement study","volume":"45","author":"Fryback","year":"2007","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long-term course of opioid addiction","volume":"23","author":"Hser","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/add.13238","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0075","series-title":"iSQoL 2 Package for Windows [webpage on the Internet]","author":"Hu","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1360-0443.2011.03443.x","article-title":"Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan","volume":"106","author":"Huang","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canep.2014.12.004","article-title":"Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy","volume":"39","author":"Hung","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0090","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1002\/hec.3512","article-title":"Estimating lifetime medical costs from censored claims data","volume":"26","author":"Hwang","year":"2017","journal-title":"Health Econ."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2","article-title":"Estimation of expected quality adjusted survival by cross-sectional survey","volume":"15","author":"Hwang","year":"1996","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0100","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.0.CO;2-D","article-title":"Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies","volume":"18","author":"Hwang","year":"1999","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:QURE.0000015299.45623.38","article-title":"Integrating health profile with survival for quality of life assessment","volume":"13","author":"Hwang","year":"2004","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0110","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1111\/dar.12616","article-title":"Substance use and population life expectancy in the USA: interactions with health inequalities and implications for policy","volume":"37","author":"Imtiaz","year":"2018","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","article-title":"Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study","volume":"2","author":"Kimber","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0120","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1524-4733.2009.00519.x","article-title":"The use of QALYs in clinical and patient decision-making: issues and prospects","volume":"12","author":"Kind","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M17-0611","article-title":"Cost-effectiveness of publicly funded treatment of opioid use disorder in California","volume":"168","author":"Krebs","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2016.05.001","article-title":"Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder","volume":"67","author":"Krebs","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0135","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1360-0443.2007.01759.x","article-title":"Persistent pain is associated with substance use after detoxification: a. Prospective cohort analysis","volume":"102","author":"Larson","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jfma.2012.12.015","article-title":"Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan","volume":"112","author":"Lee","year":"2013","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pmedr.2016.05.015","article-title":"Impact of work-related cancers in Taiwan-Estimation with QALY (quality-adjusted life year) and healthcare costs","volume":"4","author":"Lee","year":"2016","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-016-0112-3","article-title":"Effects of combination approach on harm reduction programs: the Taiwan experience","volume":"13","author":"Lin","year":"2016","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2015.10.009","article-title":"Short term health-related quality of life improvement during opioid agonist treatment","volume":"157","author":"Nosyk","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2011.04.003","article-title":"Health related quality of life trajectories of patients in opioid substitution treatment","volume":"118","author":"Nosyk","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0170","doi-asserted-by":"crossref","first-page":"E317","DOI":"10.1503\/cmaj.110669","article-title":"Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment","volume":"184","author":"Nosyk","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0175","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000488328","article-title":"Decreases of life expectancy despite decreases in non-communicable disease mortality: the role of substance use and socioeconomic status","volume":"24","author":"Rehm","year":"2018","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0185","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.289.18.2370","article-title":"Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities","volume":"289","author":"Rosenblum","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0190","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/add.14278","article-title":"Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial","volume":"113","author":"Solli","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0195","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0200","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1360-0443.2011.03656.x","article-title":"Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost\u2010effectiveness analysis","volume":"107","author":"Stephen","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0205","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.drugpo.2013.07.007","article-title":"Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV\/AIDS","volume":"24","author":"Tran","year":"2013","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/09540121.2011.608420","article-title":"Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam","volume":"24","author":"Tran","year":"2012","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugalcdep.2005.08.012","article-title":"Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population","volume":"82","author":"van der Zanden","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0220","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2013misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0225","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: the basics","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2017.04.001","article-title":"Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan","volume":"108","author":"Yang","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.drugalcdep.2019.05.003_bib0235","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s11136-015-0978-7","article-title":"Validity of EQ-5D in general population of Taiwan: results of the 2009 national health interview and drug abuse survey of Taiwan","volume":"24","author":"Yu","year":"2015","journal-title":"Qual. Life Res."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619301863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619301863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T18:13:57Z","timestamp":1562177637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619301863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"alternative-id":["S0376871619301863"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.05.003","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}